p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
暂无分享,去创建一个
Eun-Jung Lee | Mi-Sung Kim | Mi-Sung Kim | A. Moon | H. Kim | Aree Moon | Hyeong-Reh Choi Kim | Eun-Jung Lee
[1] D. Kreutzer,et al. An in vitro model of cell migration: evaluation of vascular endothelial cell migration. , 1990, Analytical biochemistry.
[2] E. Benveniste,et al. The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells* , 1999, The Journal of Biological Chemistry.
[3] Y. Cho‐Chung,et al. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. , 1987, Cancer research.
[4] D. Boyd,et al. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. , 1998, Cancer research.
[5] J. Yagüe,et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. , 1999, Blood.
[6] Marc W. Kirschner,et al. How Proteolysis Drives the Cell Cycle , 1996, Science.
[7] Mi-Sung Kim,et al. H‐ras, but not N‐ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP‐2 in the h‐ras‐induced invasive phenotype , 2000, International journal of cancer.
[8] E. Lengyel,et al. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades , 1997, Oncogene.
[9] John C. Lee,et al. Hemopoietic Growth Factors with the Exception of Interleukin-4 Activate the p38 Mitogen-activated Protein Kinase Pathway* , 1997, The Journal of Biological Chemistry.
[10] I. Fidler,et al. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.
[11] J. Hedges,et al. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. , 1999, The Journal of biological chemistry.
[12] B. Dérijard,et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.
[13] Jiahuai Han,et al. The p38 Pathway Provides Negative Feedback for Ras Proliferative Signaling* , 2000, The Journal of Biological Chemistry.
[14] C. Denkert,et al. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells , 2004, Clinical & Experimental Metastasis.
[15] K. Tryggvason,et al. Type IV collagenases in invasive tumors , 2005, Breast Cancer Research and Treatment.
[16] H. Ueno,et al. Platelet-derived Growth Factor Activates p38 Mitogen-activated Protein Kinase through a Ras-dependent Pathway That Is Important for Actin Reorganization and Cell Migration* , 1999, The Journal of Biological Chemistry.
[17] R. Muschel,et al. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. , 1990, Cancer research.
[18] David A. Cheresh,et al. Regulation of Cell Motility by Mitogen-activated Protein Kinase , 1997, The Journal of cell biology.
[19] Min Han,et al. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk‐1 phosphorylation from MAP kinase activation , 1998, The EMBO journal.
[20] E. Krebs,et al. The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] W. Yung,et al. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades , 2004, Clinical & Experimental Metastasis.
[22] I. Fidler,et al. Critical factors in the biology of human cancer metastasis. , 1995, The American surgeon.
[23] A. Brunet,et al. Identification of MAP Kinase Domains by Redirecting Stress Signals into Growth Factor Responses , 1996, Science.
[24] M. Sittinger,et al. Secretion of Gelatinases and Activation of Gelatinase A (MMP-2) by Human Rheumatoid Synovial Fibroblasts , 2001, Biological chemistry.
[25] L. Liotta,et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. , 1990, The Journal of biological chemistry.
[26] C. Harris,et al. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. , 1989, Cancer research.
[27] J. Hedges,et al. A Role for p38MAPK/HSP27 Pathway in Smooth Muscle Cell Migration* , 1999, The Journal of Biological Chemistry.
[28] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[29] S. Gruber,et al. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] C. Der,et al. Aberrant function of the Ras signal transduction pathway in human breast cancer , 1995, Breast Cancer Research and Treatment.
[31] E. Fleck,et al. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. , 1997, Hypertension.
[32] M. Stack,et al. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. , 2001, Cancer research.
[33] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[34] G. Nicolson,et al. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. , 1996, Cancer research.
[35] P. Plinkert,et al. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. , 2001, Experimental cell research.
[36] Roger J. Davis,et al. Transcriptional regulation by MAP kinases , 1995, Molecular reproduction and development.
[37] Jiahuai Han,et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.
[38] B. Dérijard,et al. Cdc42 and PAK-mediated Signaling Leads to Jun Kinase and p38 Mitogen-activated Protein Kinase Activation (*) , 1995, The Journal of Biological Chemistry.
[39] Mark S. Boguski,et al. Proteins regulating Ras and its relatives , 1993, Nature.
[40] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[41] L. M. Franks,et al. Introduction to the cellular and molecular biology of cancer , 1986 .
[42] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[43] Jacques Landry,et al. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells , 1997, Oncogene.
[44] R. Elton,et al. The H-ras oncogene product p21 and prognosis in human breast cancer , 2005, Breast Cancer Research and Treatment.
[45] J. Gutkind,et al. Role of Mitogen-activated Protein Kinases and c-Jun/AP-1 trans-Activating Activity in the Regulation of Protease mRNAs and the Malignant Phenotype in NIH 3T3 Fibroblasts* , 1999, The Journal of Biological Chemistry.
[46] M. Barbacid. ras genes. , 1987, Annual review of biochemistry.
[47] Jiahuai Han,et al. Rho Family GTPases Regulate p38 Mitogen-activated Protein Kinase through the Downstream Mediator Pak1 (*) , 1995, The Journal of Biological Chemistry.